A Safety and Efficacy Study of Dimebon in Patients With Huntington Disease

Summary

The purpose of this study is to determine if Dimebon is safe and effective for the treatment of cognitive impairment in Huntington disease.

Timeline

Start

2009-07

Primary completion

2011-07

Completion

—

Publications

• HORIZON Investigators of the Huntington Study Group and European Huntington's Disease Network. A randomized, double-blind, placebo-controlled study of latrepirdine in patients with mild to moderate Huntington disease. JAMA Neurol. 2013 Jan;70(1):25-33. doi: 10.1001/2013.jamaneurol.382.

Drugs

Indications